Murine Regulatory CD4+ T Cells Are Increased in Leukemic Spleens and Show High Co-Expression of Co-Regulatory Molecules CD39, CD73, PD1, and TIGIT
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms252111412 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Julius Krüger und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Hematology and Bone Marrow Transplantation with Section Pneumology, Hubertus Wald University Cancer Center, University Medica…. Hauptthemen laut MEDLINE: Receptors, Immunologic, Programmed Cell Death 1 Receptor, Apyrase, Spleen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Carsten Bender-Leukämie-Stiftung, Werner-Otto-Foundation, Mildred Scheel Nachwuchszentrum.
Abstract (Originalsprache)
Comprehensive characterization of AML-associated T cells during disease progression is essential to identify relevant immune escape mechanisms and new immunotherapeutic approaches. Investigating the processes that lead to an immunosuppressive environment under progression of AML is difficult in humans, because by the time of diagnosis the disease is often progressed far beyond the initial stages. Therefore, to investigate T-cell phenotypes during progression a C57BL/6 mouse model was used. The CD3+ T cells were characterized by performing multiparametric flow analyses at different time points (day 0 = healthy mice, day 7, day 14, and day 21). The study revealed that the spleen is highly infiltrated by reg CD4+ T cells at day 21 of AML progression. These spleen-infiltrating reg CD4+ T cells mainly showed an effector memory differentiation with high expression and co-expression of the checkpoint molecules TIGIT, PD-1, OX40, and the two ectoenzymes CD39 and CD73. Substantial expression of the checkpoint molecules was restricted to the central memory and effector memory compartments. Furthermore, functional evaluation of TIGIT was performed. Blocking TIGIT resulted in a significantly increased lysis of C1498 AML cells in cocultures with AML-primed CD3+ T cells. Together these data confirm that the expression of the checkpoint receptor TIGIT is relevant for dysfunction of AML-associated T cells and, thus, represents a suitable target for future immunotherapeutic approaches.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology, Hematology and Bone Marrow Transplantation with Section Pneumology, Hubertus Wald University Cancer Center, University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.
ORCID-Profile: Jasmin Wellbrock, Carsten Bokemeyer, Franziska Modemann, Walter Fiedler, Lena Behrmann
Förderung
- Carsten Bender-Leukämie-Stiftung
- Werner-Otto-Foundation
- Mildred Scheel Nachwuchszentrum
Zitieren
APA
Krüger, J., Wellbrock, J., Witt, M., Kruppa, N., Muschhammer, J., Bokemeyer, C., Modemann, F., Fiedler, W., Behrmann, L., & Brauneck, F. (2024). Murine Regulatory CD4+ T Cells Are Increased in Leukemic Spleens and Show High Co-Expression of Co-Regulatory Molecules CD39, CD73, PD1, and TIGIT. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252111412
Vancouver
Krüger J, Wellbrock J, Witt M, Kruppa N, Muschhammer J, Bokemeyer C, et al. Murine Regulatory CD4+ T Cells Are Increased in Leukemic Spleens and Show High Co-Expression of Co-Regulatory Molecules CD39, CD73, PD1, and TIGIT. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252111412
BibTeX
@article{Krger2024,
author = {Krüger, Julius and Wellbrock, Jasmin and Witt, Marius and Kruppa, Niklas and Muschhammer, Jana and Bokemeyer, Carsten and Modemann, Franziska and Fiedler, Walter and Behrmann, Lena and Brauneck, Franziska},
title = {Murine Regulatory CD4+ T Cells Are Increased in Leukemic Spleens and Show High Co-Expression of Co-Regulatory Molecules CD39, CD73, PD1, and TIGIT},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms252111412}
}
EUVIMED